Abstract:We describe several novel curcumin analogues that possess both anti-inflammatory antioxidant properties and thrombolytic activities. The therapeutic efficacy of these curcumin analogues was verified in a mouse ear edema model, a rat arterial thrombosis assay, a free radical scavenging assay performed in PC12 cells, and in both in vitro and in vivo ischemia/reperfusion models. Our findings suggest that their protective effects partially reside in maintenance of optimal mitochondrial function.
“…In our analyses, human umbilical vein endothelial (HUVEC) cells were subjected to simulated I/R injury employing a flow-through process. 31,32 During simulated ischemia, no significant cell death was observed. After exposure of cells to simulated ischemia followed by 3h of reperfusion, cell death exceeded 80%.…”
Section: Protective Effect Of Indole-tempo Conjugates In a Simulated mentioning
confidence: 93%
“…The HOMO energy, which characterizes the ability of electrondonation, is appropriate to represent the free radical scavenging efficiency of nitroxides because the process to inhibit autooxidation may include the electron-transfer in combination with the abstraction of the H-atom. [31][32][33] A higher HOMO energy implies that the molecule is a better electron donor. Because the abstraction of hydrogen involves electron transfer, the HOMO composition of a nitroxide can provide qualitative insights into the identity of its active site for the scavenging radical activity.…”
Mitochondrial oxidative damage contributes to a wide range of pathologies including ischemia/reperfusion injury. Accordingly, protecting mitochondria from oxidative damage should possess therapeutic relevance. In the present study, we have designed and synthesized a series of novel indole-TEMPO conjugates that manifested good anti-inflammatory properties in a murine model of xylene-induced ear edema. We have demonstrated that these compounds can protect cells from simulated ischemia/reperfusion (s-I/R)-induced reactive oxygen species (ROS) overproduction and mitochondrial dysfunction. Furthermore, we have demonstrated that indole-TEMPO conjugates can attenuate organ damage induced in rodents via intestinal I/R injury. We therefore propose that the pharmacological profile and mechanism of action of these indole-TEMPO conjugates involve convergent roles, including the ability to decrease free radical production via lipid peroxidation which couples to an associated decrease in ROS-mediated activation of the inflammatory process. We further hypothesize that the protective effects of indole-TEMPO conjugates partially reside in maintaining optimal mitochondrial function.
“…In our analyses, human umbilical vein endothelial (HUVEC) cells were subjected to simulated I/R injury employing a flow-through process. 31,32 During simulated ischemia, no significant cell death was observed. After exposure of cells to simulated ischemia followed by 3h of reperfusion, cell death exceeded 80%.…”
Section: Protective Effect Of Indole-tempo Conjugates In a Simulated mentioning
confidence: 93%
“…The HOMO energy, which characterizes the ability of electrondonation, is appropriate to represent the free radical scavenging efficiency of nitroxides because the process to inhibit autooxidation may include the electron-transfer in combination with the abstraction of the H-atom. [31][32][33] A higher HOMO energy implies that the molecule is a better electron donor. Because the abstraction of hydrogen involves electron transfer, the HOMO composition of a nitroxide can provide qualitative insights into the identity of its active site for the scavenging radical activity.…”
Mitochondrial oxidative damage contributes to a wide range of pathologies including ischemia/reperfusion injury. Accordingly, protecting mitochondria from oxidative damage should possess therapeutic relevance. In the present study, we have designed and synthesized a series of novel indole-TEMPO conjugates that manifested good anti-inflammatory properties in a murine model of xylene-induced ear edema. We have demonstrated that these compounds can protect cells from simulated ischemia/reperfusion (s-I/R)-induced reactive oxygen species (ROS) overproduction and mitochondrial dysfunction. Furthermore, we have demonstrated that indole-TEMPO conjugates can attenuate organ damage induced in rodents via intestinal I/R injury. We therefore propose that the pharmacological profile and mechanism of action of these indole-TEMPO conjugates involve convergent roles, including the ability to decrease free radical production via lipid peroxidation which couples to an associated decrease in ROS-mediated activation of the inflammatory process. We further hypothesize that the protective effects of indole-TEMPO conjugates partially reside in maintaining optimal mitochondrial function.
“…Moreover, they exhibited strong DPPH scavenging ability, which was about 10 times stronger than that of curcumin and has good antiproliferative activity on a variety of cancer cells, with an IC 50 value of <1 μM. Furthermore, Bi et al ( 2016 ) got a new class of derivatives that can associate apoptosis induced by ischemia/reperfusion injury and reverse mitochondrial oxidative stress. The results suggest that selected curcumin polypeptide analogs 57 (EC 50/.OH = 25.6 μM) and 58 (EC 50/.OH = 31.4 μM) exhibited good hydroxyl radical scavenging activity and can facilitate the recovery of mitochondrial reticular networks and cell rescue ( Figure 7B ).…”
Section: Application Of Amino Acids In the Structural Modification Of Natural Productsmentioning
Natural products and their derivatives are important sources for drug discovery; however, they usually have poor solubility and low activity and require structural modification. Amino acids are highly soluble in water and have a wide range of activities. The introduction of amino acids into natural products is expected to improve the performance of these products and minimize their adverse effects. Therefore, this review summarizes the application of amino acids in the structural modification of natural products and provides a theoretical basis for the structural modification of natural products in the future. The articles were divided into six types based on the backbone structures of the natural products, and the related applications of amino acids in the structural modification of natural products were discussed in detail.
“…Researchers have reported that antioxidants such as vitamin E, l -arginine, curcumin, and mitochondrion-targeted peptide protect skeletal muscle against I/R injury. 11 –14…”
Section: Introductionmentioning
confidence: 99%
“…Researchers have reported that antioxidants such as vitamin E, L-arginine, curcumin, and mitochondrion-targeted peptide protect skeletal muscle against I/R injury. [11][12][13][14] Our previous study showed that edaravone (3-methy-1-pheny1-2-pyrazolin-5-one), a potent systemic scavenger of free radicals, protects the hind limb skeletal muscles of mice against I/R injury induced by application of a tourniquet for 1.5 h. 15 Edaravone inhibits both nonenzymatic lipid peroxidation and the lipoxygenase pathway, in addition to exhibiting potent antioxidant effects against I/R injury-induced vascular endothelial cell injury, delayed neuronal death, brain edema, and concomitant neurologic deficits. Edaravone was approved for use in treating acute brain infarctions in Japan in 2002; in 2015, it was approved for treating amyotrophic lateral sclerosis based on its neuroprotective effects.…”
Purpose: The purpose of this study was to evaluate local and systemic pathology in a murine model of ischemia–reperfusion (I/R) injury induced by long-term application of a tourniquet on the hind limbs and to assess the protective effects of edaravone, a potent systemic scavenger of free radicals, using this model. Methods: Sixty C57BL6 mice were divided in two groups, with one group receiving a 3 mg/kg intraperitoneal injection of edaravone and the other group receiving an identical amount of saline 30 min before ischemia under deep anesthesia. The left thigh of each animal was constricted for 4 h with a 4.5-oz. orthodontic rubber band to induce ischemia; 4 h was the critical duration for skeletal muscles. After ischemia, specimens of skeletal muscles, both kidneys, and plasma were collected at 0, 2, 12, 24, 48, and 72 h. Injury to the skeletal muscles and vacuolar degeneration of the kidneys were histologically assessed. Additionally, apoptosis of skeletal muscle cells was assessed by analysis of caspase 3/7 activity and TUNEL staining. Plasma tumor necrosis factor (TNF)-α levels were measured using an enzyme-linked immunosorbent assay kit. Results: Skeletal muscles exhibited prominent injury of myofibers at 12 h after I/R injury, with clear upregulation of plasma TNF-α expression and histologic evidence of tubular dysfunction of the kidneys. Plasma TNF-α levels declined and histologic renal damage was ameliorated in edaravone-treated mice, but treatment did not protect skeletal muscle following ischemia for 4 h. Nonetheless, compared with group S, expression of the apoptosis marker caspase 3/7 was significantly inhibited in the skeletal hind limb muscles of Ed-group mice affected by reperfusion injury following ischemia for 4 h. Conclusion: The present study demonstrated that edaravone is a potentially useful drug for systemic or local treatment of reperfusion injury resulting from long-term ischemia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.